基因检测公司NeoGenomics（股票代码：NEO）今日盘前股价大跌24.46%，主要原因是公司公布的季度财报未能达到市场预期。
根据NeoGenomics发布的截至6月30日的季度报告，公司调整后每股收益为3美分，虽然与去年同期持平，但仅略高于分析师平均预期的2美分。然而，公司当季出现4509万美元亏损，每股亏损35美分。营收方面，虽同比增长10.2%达到1.8133亿美元，但略低于分析师预期的1.8269亿美元。
值得注意的是，NeoGenomics的股价在过去一个季度已下跌11.6%，今年迄今为止更是下跌了60.8%。尽管分析师对该公司的平均评级仍为"买入"，但过去三个月内，分析师的平均盈利预期下降了约30.7%。这些因素综合导致投资者对公司未来增长前景产生担忧，从而引发了盘前的大幅抛售。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.